Laurion Capital Management LP Makes New $370,000 Investment in The Clorox Company (NYSE:CLX)

Laurion Capital Management LP purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,281 shares of the company's stock, valued at approximately $370,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Integral Investment Advisors Inc. grew its position in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock valued at $279,000 after acquiring an additional 67 shares during the period. HCR Wealth Advisors increased its holdings in Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after acquiring an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC lifted its position in shares of Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock worth $218,000 after buying an additional 77 shares in the last quarter. Wedbush Securities Inc. grew its holdings in shares of Clorox by 1.2% in the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock valued at $1,238,000 after purchasing an additional 94 shares in the last quarter. Finally, Brooklyn Investment Group grew its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

CLX traded up $1.58 during trading on Thursday, reaching $134.99. The company's stock had a trading volume of 1,566,890 shares, compared to its average volume of 1,313,760. The firm has a fifty day simple moving average of $141.56 and a two-hundred day simple moving average of $153.64. The company has a market cap of $16.64 billion, a price-to-earnings ratio of 36.88, a PEG ratio of 2.62 and a beta of 0.60. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the business earned $1.71 EPS. The firm's quarterly revenue was down 8.0% on a year-over-year basis. As a group, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were paid a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.62%. Clorox's payout ratio is presently 87.61%.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CLX shares. Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. UBS Group dropped their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research note on Thursday, April 17th. Finally, Citigroup decreased their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $151.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.